Your browser doesn't support javascript.
loading
A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia.
Sakai, H; Hosono, N; Nakazawa, H; Przychodzen, B; Polprasert, C; Carraway, H E; Sekeres, M A; Radivoyevitch, T; Yoshida, K; Sanada, M; Yoshizato, T; Kataoka, K; Nakagawa, M M; Ueno, H; Nannya, Y; Kon, A; Shiozawa, Y; Takeda, J; Shiraishi, Y; Chiba, K; Miyano, S; Singh, J; Padgett, R A; Ogawa, S; Maciejewski, J P; Makishima, H.
Afiliación
  • Sakai H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Hosono N; Division of Hematology, Department of Internal Medicine, Shinshu University, Matsumoto, Japan.
  • Nakazawa H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Przychodzen B; Division of Hematology, Department of Internal Medicine, Shinshu University, Matsumoto, Japan.
  • Polprasert C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Carraway HE; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Sekeres MA; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Radivoyevitch T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Yoshida K; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Sanada M; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Yoshizato T; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Kataoka K; Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Nakagawa MM; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Ueno H; Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Nannya Y; Clinical Research Center, Nagoya Medical Center, Nagoya, Japan.
  • Kon A; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Shiozawa Y; Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Takeda J; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Shiraishi Y; Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Chiba K; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Miyano S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Singh J; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Padgett RA; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Ogawa S; Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Maciejewski JP; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
  • Makishima H; Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Leukemia ; 32(3): 839-843, 2018 03.
Article en En | MEDLINE | ID: mdl-29099495

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fenotipo / Factores de Transcripción / Variación Genética / Síndromes Mielodisplásicos Tipo de estudio: Prognostic_studies Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fenotipo / Factores de Transcripción / Variación Genética / Síndromes Mielodisplásicos Tipo de estudio: Prognostic_studies Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article